Annualised rate of asthma exacerbations¶ | | | |
Clinically significant exacerbations | 0.54 (0.47–0.61) | 0.51 (0.44–0.58) | 0.48 (0.43–0.55) |
Exacerbations resulting in ED visit or hospitalisation | 0.65 (0.46–0.93) | 0.48 (0.31–0.73) | 0.48 (0.33–0.68) |
Change in pre-bronchodilator FEV1 L+ | | | |
From baseline to week 32 | 0.11 (0.05–0.18) | 0.07 (0.02–0.13) | 0.10 (0.04–0.17) |
From baseline to end of study§ | 0.11 (0.05–0.18) | 0.09 (0.04–0.14) | 0.11 (0.04–0.17) |
From baseline to end of study, excluding data from MENSA | 0.11 (0.05–0.18) | 0.06 (–0.04–0.16)ƒ | 0.09 (0.03–0.14)# |